查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球智慧胰島素筆市場評估：按類型、按適應症、按用途、按產品、按連接性、按最終用戶、按分銷渠道、按地區、機會、預測（2017-2031）
市場調查報告書
商品編碼
1422083

全球智慧胰島素筆市場評估：按類型、按適應症、按用途、按產品、按連接性、按最終用戶、按分銷渠道、按地區、機會、預測（2017-2031）

Smart Insulin Pens Market Assessment, By Type, By Indication, By Usability, By Product, By Connectivity, By End-user, By Distribution Channel, By Region, By Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5個工作天內

價格

預計2023年全球智慧胰島素筆市場規模將達到5,140萬美元，2031年將達到1.2909億美元，2024-2031年預測期間複合年增長率為12.2%。Masu。 糖尿病盛行率的增加、血糖控制的改善、患者便利性的提高、技術的持續進步、對遠距醫療的重視、意識的提高、用藥錯誤風險的最小化、潛在的醫療成本節省等。眾多因素正在推動全球智慧胰島素筆市場的發展。

全球智慧胰島素筆市場代表了糖尿病管理的重大飛躍。 這些突破性的設備徹底改變了糖尿病患者的胰島素給藥流程，提供更高的準確性、便利性和數據驅動的見解，以改善整體福祉和生活品質。 全球糖尿病流行以及對高效且易於使用的糖尿病管理工具日益增長的需求正在推動全球智慧胰島素筆市場的擴張。 醫療保健提供者和患者越來越認識到這些設備改善胰島素治療的潛力，從而實現更有效的血糖控制並減少與糖尿病相關的長期併發症。

隨著製造商技術進步並推出日益複雜的功能和連接選項，全球智慧胰島素筆市場將持續成長。 智慧胰島素筆採用的技術可促進自動、準確的劑量計算，減少胰島素注射過程中人為錯誤的可能性。 這些設備通常與智慧型手機應用程式建立無線連接，允許用戶追蹤胰島素劑量歷史、血糖水平和其他重要數據。 這為改善糖尿病管理和提高患有這種慢性疾病的人的獨立性提供了廣闊的前景。

提高意識

人們對使用智慧方法監測和控製糖尿病的意識不斷增強，導致全球智慧胰島素筆市場顯著成長。 糖尿病照護正在從傳統的面對面就診轉向視訊就診等同步遠距醫療方法，以及主要由市場新創公司提供的越來越多的非同步數位醫療服務。 過去幾十年來，胰島素筆的使用在美國穩步增加，並已成為第 1 型糖尿病 (T1D) 和第 2 型糖尿病 (T2D) 患者的首選胰島素給藥方法。 目前，胰島素筆在商業保險個人中佔據主導地位。 患者選擇胰島素筆是因為它們比胰島素瓶或註射器方法更令人滿意且更容易使用。 這些筆提供卓越的劑量準確性，從而提高胰島素依從性。 此外，胰島素筆的使用降低了 HbA1c 水平，最大限度地減少了高血糖，並顯示出更好的血糖控制。 儘管初始成本較高，胰島素筆可降低總醫療成本，從而減少住院治療、糖尿病相關住院治療以及高血糖相關醫療保健利用率。

科技進步推動市場前進

技術創新改變了全球智慧胰島素筆市場的格局。 這些發展包括準確的劑量計算、即時智慧型手機數據整合、用戶友好的介面等等。 智慧胰島素筆的發展為人們提供了管理健康的有效手段，最終提高了福祉並提高了生活品質。 例如，2023 年 3 月，自動胰島素輸送領域的先驅 Diabeloop 宣布與全球著名醫療保健公司諾和諾德建立合作關係。 兩家公司的工作重點是推動包含連網胰島素筆的互通性策略。 該協議涵蓋Diabeloop 的自學習MDI（每日多次注射）治療演算法、DBL-4pen(TM) 和可重複使用的連接設備，例如諾和諾德的NovoPen(R) 6 和NovoPen Echo(R) Plus ，還包括胰島素筆集成。

本報告研究分析了全球智慧胰島素筆市場，提供市場規模和預測、市場動態、主要參與者現狀和前景等。

目錄

第 1 章研究方法

第 2 章專案範圍與定義

第 3 章 COVID-19 對全球智慧胰島素筆市場的影響

第 4 章執行摘要

第 5 章全球智慧胰島素筆市場展望（2014-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 依類型
    • 第一代筆
    • 第二代筆
  • 依指示
    • 1 型糖尿病
    • 2 型糖尿病
  • 使用性別
    • 一次性
    • 可重複使用
  • 按產品
    • 智慧型胰島素筆
    • 傳統筆的轉接器
  • 按最終用戶
    • 醫院、診所
    • 門診手術中心
    • 居家照護環境
  • 按分銷管道
    • 診所、門診手術中心
    • 電子商務
    • 零售藥局
  • 按地區
    • 北美
    • 南美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 6 章全球智慧胰島素筆市場展望：按地區劃分（2014-2031 年）

  • 北美
    • 市場規模與預測
    • 依類型
    • 依指示
    • 使用性別
    • 按產品
    • 按最終用戶
    • 按分銷管道
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 7 章市場地圖（2023 年）

  • 依類型
  • 依指示
  • 使用性別
  • 按產品
  • 按最終用戶
  • 按分銷管道
  • 按地區

第 8 章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 9 章市場動態

  • 生長促進因素
  • 生長抑制因素（問題、限制因素）

第 10 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新技術

第 11 章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家公司進入市場）
  • 專利分析（如果適用）

第 12 章價格分析

第 13 章案例研究

第 14 章主要公司展望

  • Novo Nordisk A/S
  • Medtronic plc.
  • Sanofi S.A.
  • Eli Lilly International Corp.
  • Dexcom, Inc.
  • Emperra GmbH E-Health Technologies
  • Bigfoot Biomedical, INC.
  • Jiangsu Delfu medical device Co. Ltd.
  • Digital Medics Pty Ltd.
  • Glooko XT
  • Biocorp Production
  • Pendiq GmbH

第 15 章策略建議

第 16 章關於我們公司，免責聲明

Product Code: MX10948

Global Smart Insulin Pens Market size was valued at USD 51.4 million in 2023, expected to reach USD 129.09 million in 2031 with a CAGR of 12.2% for the forecast period between 2024 and 2031F. Numerous factors are propelling the global smart insulin pens market forward, including the increasing prevalence of diabetes, better management of glycaemic levels, increased patient convenience, ongoing technological progress, a heightened emphasis on telehealth, growing awareness, minimized medication error risk, and potential healthcare cost reductions.

The global smart insulin pens market signifies a significant leap forward in diabetes management. These groundbreaking devices have revolutionized the insulin administration process for people with diabetes, providing them with improved accuracy, convenience, and data-driven insights to improve their overall well-being and quality of life. The escalating global diabetes prevalence and the growing need for efficient and user-friendly diabetes management tools have fuelled the expansion of the global smart insulin pens market. Both healthcare providers and patients are increasingly acknowledging the potential of these devices to improve insulin therapy, leading to more effective glycaemic control and a reduction in the long-term complications associated with diabetes.

With the evolution of technology and the introduction of increasingly sophisticated features and connectivity choices by manufacturers, the global smart insulin pens market is positioned for ongoing growth. Smart insulin pens are furnished with technology that facilitates automated and precise dose calculations, diminishing the potential for human errors during insulin administration. These devices frequently establish wireless connections with smartphone applications, enabling users to track their insulin dosing history, blood glucose levels, and other vital data. This presents a promising outlook for improved diabetes management and increased independence for individuals with this chronic condition.

Growing Awareness

The increased awareness of using smart methods to monitor and control diabetes has led to significant growth in the global smart insulin pens market. Diabetes care is transitioning from traditional in-person office visits to synchronous telehealth methods, such as video consultations, and increasingly, asynchronous digital healthcare services, primarily provided by emerging players in the market. In the United States, the utilization of insulin pens has witnessed a consistent rise over the past few decades, becoming the preferred mode of insulin delivery for both type 1 diabetes (T1D) and type 2 diabetes (T2D) patients. Insulin pens now dominate the market among commercially insured individuals. Patients opt for insulin pens due to their high satisfaction levels and user-friendliness compared to insulin vial and syringe methods. These pens offer superior dose accuracy, leading to improved insulin adherence. Moreover, insulin pen usage has demonstrated better glycaemic controls, reducing HbA1c levels and minimizing hyperglycemia. Despite initial higher costs, insulin pens translate into lower total healthcare expenses, resulting in fewer hospitalizations, diabetes-related admissions, and instances of hyperglycemia-associated healthcare utilization for users.

Advancements in Technology are Propelling the Market Forward

Innovations in technology have transformed the realm of the global smart insulin pens market. These developments include precise dose computations, immediate smartphone data integration, and user-friendly interfaces. The evolution of smart insulin pens provides individuals with efficient means of managing their health, ultimately resulting in enhanced well-being and a better quality of life. For example, in March 2023, Diabeloop, a trailblazer in Automated Insulin Delivery, revealed a partnership with Novo Nordisk, a prominent global healthcare firm. Their joint effort focuses on advancing an interoperability strategy incorporating connected insulin pens. The agreement involves the integration of Diabeloop's self-learning algorithm for Multiple Daily Injections (MDI) therapy, DBL-4pen™, with Novo Nordisk's connected and reusable insulin pens, including NovoPen® 6 and NovoPen Echo® Plus.

Government Initiatives

Government programs focusing on smart insulin pens are pivotal in tackling the worldwide diabetes crisis and improving the well-being of those afflicted with the condition. Governments efforts give a huge boost to global smart insulin pens market. These efforts reflect a forward-looking approach governments took to combat the increasing incidence of diabetes and the escalating need for cutting-edge solutions in diabetes care and management. On January 1, 2023, a notable development occurred as smart insulin pens were incorporated into Medicare Part D by the US government. This means that individuals enrolled in Medicare who rely on smart insulin pens will now have their expenses capped at a maximum of $35 per month for a one-month supply of each approved insulin product. This pivotal inclusion of smart insulin pens in Medicare Part D was mandated under the Affordable Care Act, commonly known as Obamacare. The ACA mandates Medicare to encompass specific categories of diabetes-related supplies, among them being insulin pens. Such initiatives have a large impact on the global smart insulin pens market.

Growing Demand for Bluetooth Devices

The advent of Bluetooth-enabled smart insulin pens marks a substantial advancement in global smart insulin pens market. These cutting-edge tools amalgamate the precision inherent in conventional insulin pens with the capabilities of Bluetooth connectivity, presenting users with a cohesive and data-centric methodology for managing their insulin therapy. By facilitating immediate data transfer to smartphones and other suitable devices, these smart insulin pens empower individuals managing diabetes to meticulously monitor their insulin doses, oversee blood glucose levels, receive dose guidance, and seamlessly communicate vital health data with healthcare professionals. As an example, in December 2022, Biocorp, a French firm specializing in medical devices and drug delivery systems, unveiled its FDA 510(k) clearance to commercialize the Mallya smart medical device, designed to interface with insulin pens. Mallya, functioning as a smart sensor, seamlessly affixes to insulin pen injectors, effectively transforming them into connected devices via bluetooth.

Disposable Smart Insulin Pens are Becoming More Popular

Disposable smart insulin pens are reshaping diabetes management by merging the simplicity of one-time-use pens with state-of-the-art technology, ultimately influencing the global smart insulin pens market. These compact instruments come pre-filled with insulin and boast smart capabilities like dosage monitoring, reminders, and wireless connectivity. This enables users to administer insulin with accuracy while effortlessly overseeing their treatment progress. The disposability factor removes the necessity for cartridge swaps, streamlining insulin administration and boosting patient adherence. As an example, in November 2021, the French multinational pharmaceutical and healthcare company Sanofi and the Swiss multinational healthcare company Roche established a collaborative effort in France. They united their efforts to promote the utilization of a connected accessory designed for disposable insulin pens. Together, they will create an educational program for healthcare professionals, including physicians and retail pharmacists, focusing on the Biocorp product known as Mallya.

Impact of COVID-19

COVID-19 pandemic had a huge impact on the global smart insulin pens market. On one hand, the demand for smart insulin pens surged during the pandemic, primarily driven by the heightened vulnerability of people with diabetes to severe COVID-19 complications, given their increased susceptibility to respiratory infections. This elevated demand was fueled by the urgency for effective diabetes management to reduce hospitalization risks. Conversely, the pandemic disrupted the supply chain for smart insulin pens as production facilities and distribution networks faced closures and shipping challenges, leading to shortages in certain regions. However, despite these short-term setbacks, the long-term outlook for smart insulin pen sales remains positive. COVID-19 underscored the critical importance of effective diabetes management, shedding light on the role smart insulin pens can play in empowering individuals with diabetes to manage their condition proactively and remotely. This heightened awareness is expected to drive sustained growth in the smart insulin pens market.

Key Players Landscape and Outlook

Amidst the rapidly changing healthcare environment, marked by a strong emphasis on precision, connectivity, and patient-centric care, the global market for smart insulin pens is experiencing a multitude of partnerships and cooperative ventures. These endeavors frequently bring together a diverse array of stakeholders, including pharmaceutical firms, technology enterprises, startups, and healthcare providers, who combine their knowledge and resources with the goal of creating advanced smart insulin pens. These next-generation devices aim not only to enhance insulin delivery precision but also to offer users immediate data insights and the ability to remotely monitor their insulin therapy. In May 2021, Eli Lilly & Co., an American pharmaceutical company, took steps to ensure the compatibility of its forthcoming connected insulin pen system with various daily diabetes management platforms by entering into compatibility agreements with four global providers. These agreements encompass a range of offerings, such as glucose monitoring sensors, digital health solutions, and other resources provided by Roche, Dexcom, Glooko, and myDiabby Healthcare.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global Smart Insulin Pens Market

4. Executive Summary

5. Global Smart Insulin Pens Market Outlook, 2014-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. First Generation Pens
    • 5.2.2. Second Generation Pens
  • 5.3. By Indications
    • 5.3.1. Type 1 Diabetes
    • 5.3.2. Type 2 Diabetes
  • 5.4. By Usability
    • 5.4.1. Disposable
    • 5.4.2. Reusable
  • 5.5. By Product
    • 5.5.1. Smart Insulin Pens
    • 5.5.2. Adaptors for Conventional Pens
  • 5.6. By End-user
    • 5.6.1. Hospital and Clinics
    • 5.6.2. Ambulatory Surgical Centers
    • 5.6.3. Home Care Settings
  • 5.7. By Distribution Channel
    • 5.7.1. Clinics and Ambulatory Surgical Centers
    • 5.7.2. E-commerce
    • 5.7.3. Retail Pharmacies
  • 5.8. By Region
    • 5.8.1. North America
    • 5.8.2. South America
    • 5.8.3. Europe
    • 5.8.4. Asia-Pacific
    • 5.8.5. Middle East and Africa
  • 5.9. By Company Market Share (%), 2023

6. Global Malaria Vaccine Market Outlook, By Region, 2014-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Type
      • 6.1.2.1. First Generation Pens
      • 6.1.2.2. Second Generation Pens
    • 6.1.3. By Indication
      • 6.1.3.1. Type 1 Diabetes
      • 6.1.3.2. Type 2 Diabetes
    • 6.1.4. By Usability
      • 6.1.4.1. Disposable
      • 6.1.4.2. Reusable
    • 6.1.5. By Product
      • 6.1.5.1. Smart Insulin Pens
      • 6.1.5.2. Adaptors for Conventional Pens
    • 6.1.6. By End-user
      • 6.1.6.1. Hospital and Clinics
      • 6.1.6.2. Ambulatory Surgical Centers
      • 6.1.6.3. Home Care Settings
    • 6.1.7. By Distribution Channel
      • 6.1.7.1. Clinics and Ambulatory Surgical Centers
      • 6.1.7.2. E-commerce
      • 6.1.7.3. Retail Pharmacies
    • 6.1.8. United States*
      • 6.1.8.1. Market Size & Forecast
      • 6.1.8.1.1. Value
      • 6.1.8.1.2. Volume
      • 6.1.8.2. By Type
      • 6.1.8.2.1. First Generation Pens
      • 6.1.8.2.2. Second Generation Pens
      • 6.1.8.3. By Indication
      • 6.1.8.3.1. Type 1 Diabetes
      • 6.1.8.3.2. Type 2 Diabetes
      • 6.1.8.4. By Usability
      • 6.1.8.4.1. Disposable
      • 6.1.8.4.2. Reusable
      • 6.1.8.5. By Product
      • 6.1.8.5.1. Smart Insulin Pens
      • 6.1.8.5.2. Adaptors for Conventional Pens
      • 6.1.8.6. By End-user
      • 6.1.8.6.1. Hospital and Clinics
      • 6.1.8.6.2. Ambulatory Surgical Centers
      • 6.1.8.6.3. Home Care Settings
      • 6.1.8.7. By Distribution Channel
      • 6.1.8.7.1. Clinics and Ambulatory Surgical Centers
      • 6.1.8.7.2. E-commerce
      • 6.1.8.7.3. Retail Pharmacies
      • 6.1.8.8. By Region
      • 6.1.8.8.1. North America
      • 6.1.8.8.2. South America
      • 6.1.8.8.3. Europe
      • 6.1.8.8.4. Asia-Pacific
      • 6.1.8.8.5. Middle East and Africa
    • 6.1.9. Canada
    • 6.1.10. Mexico

All segments will be provided for all regions and countries covered:

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Indication
  • 7.3. By Usability
  • 7.4. By Product
  • 7.5. By End-user
  • 7.6. By Distributional Channel
  • 7.7. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Novo Nordisk A/S
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Medtronic plc.
  • 14.3. Sanofi S.A.
  • 14.4. Eli Lilly International Corp.
  • 14.5. Dexcom, Inc.
  • 14.6. Emperra GmbH E-Health Technologies
  • 14.7. Bigfoot Biomedical, INC.
  • 14.8. Jiangsu Delfu medical device Co. Ltd.
  • 14.9. Digital Medics Pty Ltd.
  • 14.10. Glooko XT
  • 14.11. Biocorp Production
  • 14.12. Pendiq GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 3. Global Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 5. Global Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 6. Global Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 7. Global Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 8. Global Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 9. Global Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 10. Global Smart Insulin Pens Market Share (%), By Region, 2017-2031F
  • Figure 11. North America Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 12. North America Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 13. North America Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 14. North America Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 15. North America Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 16. North America Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 17. North America Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 18. North America Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 19. North America Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 20. North America Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 21. United States Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 22. United States Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 23. United States Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 24. United States Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 25. United States Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 26. United States Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 27. United States Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 28. United States Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 29. United States Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 30. Canada Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 31. Canada Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 32. Canada Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 33. Canada Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 34. Canada Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 35. Canada Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 36. Canada Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 37. Canada Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 38. Canada Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 39. Mexico Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 40. Mexico Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 41. Mexico Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 42. Mexico Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 43. Mexico Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 44. Mexico Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 45. Mexico Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 46. Mexico Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 47. Mexico Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 48. Europe Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 49. Europe Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 50. Europe Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 51. Europe Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 52. Europe Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 53. Europe Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 54. Europe Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 55. Europe Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 56. Europe Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 57. Europe Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 58. Germany Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 59. Germany Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 60. Germany Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 61. Germany Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 62. Germany Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 63. Germany Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 64. Germany Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 65. Germany Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 66. Germany Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 67. France Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 68. France Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 69. France Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 70. France Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 71. France Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 72. France Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 73. France Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 74. France Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 75. France Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 76. Italy Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Italy Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 78. Italy Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 79. Italy Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 80. Italy Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 81. Italy Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 82. Italy Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 83. Italy Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 84. Italy Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 85. United Kingdom Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 86. United Kingdom Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 87. United Kingdom Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 88. United Kingdom Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 89. United Kingdom Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 90. United Kingdom Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 91. United Kingdom Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 92. United Kingdom Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 93. United Kingdom Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. Russia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 95. Russia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 96. Russia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 97. Russia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 98. Russia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 99. Russia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 100. Russia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 101. Russia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 102. Russia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 103. Netherlands Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 104. Netherlands Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 105. Netherlands Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 106. Netherlands Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 107. Netherlands Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 108. Netherlands Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 109. Netherlands Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 110. Netherlands Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 111. Netherlands Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 112. Spain Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 113. Spain Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 114. Spain Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 115. Spain Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 116. Spain Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 117. Spain Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 118. Spain Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 119. Spain Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 120. Spain Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 121. Turkey Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 122. Turkey Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 123. Turkey Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 124. Turkey Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 125. Turkey Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 126. Turkey Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 127. Turkey Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 128. Turkey Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 129. Turkey Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 130. Poland Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 131. Poland Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 132. Poland Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 133. Poland Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 134. Poland Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 135. Poland Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 136. Poland Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 137. Poland Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 138. Poland Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 139. South America Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 140. South America Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 141. South America Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 142. South America Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 143. South America Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 144. South America Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 145. South America Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 146. South America Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 147. South America Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 148. South America Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 149. Brazil Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 150. Brazil Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 151. Brazil Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 152. Brazil Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 153. Brazil Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 154. Brazil Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 155. Brazil Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 156. Brazil Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 157. Brazil Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 158. Argentina Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 159. Argentina Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 160. Argentina Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 161. Argentina Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 162. Argentina Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 163. Argentina Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 164. Argentina Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 165. Argentina Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 166. Argentina Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 167. Asia-Pacific Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 168. Asia-Pacific Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 169. Asia-Pacific Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 170. Asia-Pacific Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 171. Asia-Pacific Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 172. Asia-Pacific Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 173. Asia-Pacific Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 174. Asia-Pacific Smart Insulin Pens Market Share (%), By End-user, In USD Million, 2016-2030
  • Figure 175. Asia-Pacific Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 176. Asia-Pacific Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 177. India Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 178. India Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 179. India Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 180. India Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 181. India Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 182. India Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 183. India Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 184. India Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 185. India Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 186. China Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 187. China Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 188. China Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 189. China Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 190. China Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 191. China Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 192. China Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 193. China Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 194. China Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195. Japan Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 196. Japan Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 197. Japan Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 198. Japan Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 199. Japan Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 200. Japan Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 201. Japan Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 202. Japan Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 203. Japan Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 204. Australia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 205. Australia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 206. Australia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 207. Australia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 208. Australia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 209. Australia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 210. Australia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 211. Australia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 212. Australia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 213. Vietnam Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 214. Vietnam Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 215. Vietnam Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 216. Vietnam Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 217. Vietnam Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 218. Vietnam Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 219. Vietnam Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 220. Vietnam Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 221. Vietnam Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 222. South Korea Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 223. South Korea Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 224. South Korea Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 225. South Korea Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 226. South Korea Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 227. South Korea Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 228. South Korea Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 229. South Korea Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 230. South Korea Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 231. Indonesia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 232. Indonesia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 233. Indonesia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 234. Indonesia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 235. Indonesia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 236. Indonesia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 237. Indonesia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 238. Indonesia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 239. Indonesia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 240. Philippines Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 241. Philippines Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 242. Philippines Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 243. Philippines Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 244. Philippines Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 245. Philippines Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 246. Philippines Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 247. Philippines Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 248. Philippines Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 249. Middle East & Africa Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 250. Middle East & Africa Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 251. Middle East & Africa Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 252. Middle East & Africa Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 253. Middle East & Africa Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 254. Middle East & Africa Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 255. Middle East & Africa Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 256. Middle East & Africa Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 257. Middle East & Africa Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 258. Middle East & Africa Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 259. Saudi Arabia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 260. Saudi Arabia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 261. Saudi Arabia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 262. Saudi Arabia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 263. Saudi Arabia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 264. Saudi Arabia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 265. Saudi Arabia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 266. Saudi Arabia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 267. Saudi Arabia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 268. UAE Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 269. UAE Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 270. UAE Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 271. UAE Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 272. UAE Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 273. UAE Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 274. UAE Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 275. UAE Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 276. UAE Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 277. South Africa Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 278. South Africa Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 279. South Africa Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 280. South Africa Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 281. South Africa Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 282. South Africa Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 283. South Africa Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 284. South Africa Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 285. South Africa Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 286. By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 287. By Indication Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 288. By Usability Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 289. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 290. By Connectivity Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 291. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 292. By Distribution Channel Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 293. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023